Vice President, Global Program Head Greater New York City, NY Area
About the Role
Greater New York City, NY Area (Hybrid)(Princeton, New Jersey)
The Company is seeking a Vice President, Global Program Head to lead a therapeutic program from late-stage development through regulatory submission, launch, and lifecycle management. The role owns the program’s integrated strategy, plan, milestones, budget, and resource needs, using scientific, clinical, regulatory, and commercial evidence to guide priorities and key decisions. The successful candidate will lead a global, cross-functional team, address risks and obstacles, and coordinate launch readiness and engagement with health authorities. They will also communicate program progress and investment needs to senior leadership and the board, represent the program with external partners, and mentor team members. Candidates must hold an advanced degree in life sciences or medicine, such as an MD or PhD, and have a track record of advancing programs through major clinical and regulatory milestones. Required strengths include strategic and analytical judgment, cross-functional leadership, negotiation, conflict resolution, and excellent written and verbal communication. Preferred qualifications include at least 10 years of biopharmaceutical drug development experience, including early- and late-phase programs, and experience leading and developing teams. Cardiovascular or cardiometabolic development, regulatory filing and approval, external collaborations, multiple therapeutic modalities, and strong budgeting and planning skills are also valued.
Functions:
- Strategy
- Operations
Compensation
USD $312,000-$373,000 (salary) per year
About the Company
Innovative biotechnology (BioTech) company specializing in cardiovascular drugs
Industry
Biotechnology
Type
Privately Held, VC-backed
Age
employees
51-200
Funding
>$200m